COURAGE CLINICAL OUTCOMES UTILIZING REVASCULARIZATION & AGGRESSIVE DRUG EVAL
勇气利用血运重建的临床结果
基本信息
- 批准号:7376566
- 负责人:
- 金额:$ 3.78万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-04-05 至 2007-02-28
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Coronary artery disease is a process that results in "hardening the arteries." When the arteries that supply blood and oxygen to your heart muscle become clogged or narrowed, a heart attack may result, or you may feel chest discomfort (angina) sometimes even while resting. The best treatment for patients like yourself with coronary artery disease is unclear. There are three kinds of approaches: treatment with medicines, coronary artery bypass (open heart) surgery, and balloon angioplasty. Balloon angioplasty has been used safely in patients like yourself for over 15 years. It is a technique for widening the narrowed arteries in the heart by either inflating a small balloon placed in the narrowed area or using a special device (rotoblator) to burrow through, or shave (directional atherectomy), plaques of calcium from the narrowed areas. Sometimes a small expandable stainless steel mesh tube (stent) is placed in the artery to assist it in remaining open. It has not been proven in patients like yourself whether those who have balloon angioplasty live longer, have fewer heart attacks, or have a better quality of life than those who only have medicine. The American Heart Association has developed guidelines for intensive treatment of patients with coronary artery disease with medicines. These medicines include aspirin, drugs that decrease the work of the heart (beta-blockers), drugs that relax the coronary arteries so that more blood can flow through the narrowed artery (nitroglycerin, calcium channel blockers), drugs that lower blood pressure, drugs that decrease cholesterol and blood fats, and for women, an estrogen supplement. In addition to medicines, these guidelines include recommendations to pay attention to diet and exercise and to stop smoking. The purpose of this study is to determine whether in patients like yourself, adding balloon angioplasty to the medical therapy suggested by the American Heart Association will result in fewer deaths and heart attacks or a better quality of life than treatment with medical therapy alone. All patients receive maximum medical therapy and half of the patients will receive a percutaneous procedure (PCI). Patients will be followed for 3-5 years to follow their cardiac symptoms.
该子项目是利用NIH/NCRR资助的中心赠款提供的资源的许多研究子项目之一。子项目和研究者(PI)可能从另一个NIH来源获得主要资金,因此可以在其他CRISP条目中表示。所列机构为中心,不一定是研究者所在机构。冠状动脉疾病是一个导致“动脉硬化"的过程。“当为心肌提供血液和氧气的动脉堵塞或狭窄时,可能会导致心脏病发作,或者即使在休息时,有时也会感到胸部不适(心绞痛)。对于像你这样的冠心病患者,最好的治疗方法还不清楚。有三种方法:药物治疗,冠状动脉搭桥术(心脏直视手术)和球囊血管成形术。球囊血管成形术已经安全地用于像你这样的病人超过15年。它是一种用于扩大心脏狭窄动脉的技术,通过在狭窄区域放置一个小球囊或使用一种特殊的设备(旋切器)来钻穿或刮除(定向斑块切除术)狭窄区域的钙斑块。有时,一个小的可膨胀的不锈钢网状管(支架)被放置在动脉中,以帮助它保持开放。在像你这样的患者中,还没有证明那些接受球囊血管成形术的人是否比那些只接受药物治疗的人活得更长,心脏病发作更少,或者生活质量更好。美国心脏协会已经制定了对冠状动脉疾病患者进行药物强化治疗的指南。这些药物包括阿司匹林,降低心脏工作的药物(β受体阻滞剂),放松冠状动脉的药物,以便更多的血液可以通过狭窄的动脉(硝酸甘油,钙通道阻滞剂),降低血压的药物,降低胆固醇和血脂的药物,以及女性雌激素补充剂。除了药物外,这些指南还包括注意饮食和锻炼以及戒烟的建议。这项研究的目的是确定在像你这样的患者中,将球囊血管成形术添加到美国心脏协会建议的药物治疗中是否会导致更少的死亡和心脏病发作,或者比单独使用药物治疗更好的生活质量。所有患者均接受最大限度的药物治疗,一半患者将接受经皮手术(PCI)。将对患者进行3-5年的随访,以跟踪其心脏症状。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ERIC R BATES其他文献
ERIC R BATES的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ERIC R BATES', 18)}}的其他基金
BARI-2D - BYPASS ANGIOPLASTY REVASCULARIZATION INVESTIGATION 2 DIABETES
BARI-2D - 旁路血管成形术血运重建研究 2 糖尿病
- 批准号:
7603774 - 财政年份:2007
- 资助金额:
$ 3.78万 - 项目类别:
COURAGE CLINICAL OUTCOMES UTILIZING REVASCULARIZATION & AGGRESSIVE DRUG EVAL
勇气利用血运重建的临床结果
- 批准号:
7603744 - 财政年份:2007
- 资助金额:
$ 3.78万 - 项目类别:
BARI-2D BYPASS ANGIOPLASTY REVASCULARIZATION INVESTIGATION 2 DIABETES
BARI-2D 旁路血管成形术血运重建研究 2 糖尿病
- 批准号:
7376610 - 财政年份:2006
- 资助金额:
$ 3.78万 - 项目类别:
COURAGE CLINICAL OUTCOMES UTILIZING REVASCULARIZATION & AGGRESSIVE DRUG EVAL
勇气利用血运重建的临床结果
- 批准号:
7199895 - 财政年份:2005
- 资助金额:
$ 3.78万 - 项目类别:
BARI-2D BYPASS ANGIOPLASTY REVASCULARIZATION INVESTIGATION 2 DIABETES
BARI-2D 旁路血管成形术血运重建研究 2 糖尿病
- 批准号:
7199933 - 财政年份:2005
- 资助金额:
$ 3.78万 - 项目类别:
COURAGE Clinical Outcomes Utilizing Revascularization & Aggressive Drug Eval.
COURAGE 利用血运重建的临床结果
- 批准号:
7039861 - 财政年份:2004
- 资助金额:
$ 3.78万 - 项目类别:
相似国自然基金
基于MFSD2A调控血迷路屏障跨细胞囊泡转运机制的噪声性听力损失防治研究
- 批准号:82371144
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
内源性蛋白酶抑制剂SerpinA3N对缺血性脑卒中后血脑屏障的保护作用及其表达调控机制
- 批准号:82371317
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
骨骼肌中胰高血糖素受体的表达及其调控血糖稳态的作用与机制研究
- 批准号:82370820
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
KLK10调控胶质—血管耦合与对话促缺血性卒中后血脑屏障修复的机制
- 批准号:82371465
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
气体信号分子硫化氢对颈动脉窦压力反射感受器的调节作用及机制
- 批准号:81100181
- 批准年份:2011
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
精神分裂症特异微小RNA的筛选、鉴定及其靶向调控功能研究
- 批准号:81000583
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
人脐血间充质干细胞成骨潜能亚群的特异性分子标志
- 批准号:30800232
- 批准年份:2008
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Development of nextgeneration cellular artificial blood vessels for coronary artery bypass surgery using bio-3D printer
使用生物 3D 打印机开发用于冠状动脉搭桥手术的下一代细胞人造血管
- 批准号:
23H02991 - 财政年份:2023
- 资助金额:
$ 3.78万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Whole genome sequence interpretation for lipids to discover new genes and mechanisms for coronary artery disease
脂质的全基因组序列解释,以发现冠状动脉疾病的新基因和机制
- 批准号:
10722515 - 财政年份:2023
- 资助金额:
$ 3.78万 - 项目类别:
Molecular predictors of cardiovascular events and resilience in chronic coronary artery disease
心血管事件的分子预测因素和慢性冠状动脉疾病的恢复力
- 批准号:
10736587 - 财政年份:2023
- 资助金额:
$ 3.78万 - 项目类别:
Repetitive Stretch-Induced Myocardial Stiffening in Chronic Coronary Artery Disease
慢性冠状动脉疾病中反复牵拉引起的心肌硬化
- 批准号:
10588929 - 财政年份:2023
- 资助金额:
$ 3.78万 - 项目类别:
PRE-DETERMINE: Advancing Sudden Arrhythmic Death Prediction in Coronary Artery Disease in the Absence of Severe Systolic Dysfunction
预先确定:在没有严重收缩功能障碍的情况下推进冠状动脉疾病的心律失常性猝死预测
- 批准号:
10608859 - 财政年份:2023
- 资助金额:
$ 3.78万 - 项目类别:
Racial Disparities in Sleep, Circadian Rhythm, and Glucoregulation Among Individuals Post-Coronary Artery Bypass Surgery
冠状动脉搭桥手术后个体在睡眠、昼夜节律和血糖调节方面的种族差异
- 批准号:
10750187 - 财政年份:2023
- 资助金额:
$ 3.78万 - 项目类别:
Thiamine Intervention and Cognition in Older Adults Undergoing Coronary Artery Bypass Grafting- A Randomized Clinical Trial
接受冠状动脉搭桥术的老年人的硫胺素干预和认知——一项随机临床试验
- 批准号:
10811014 - 财政年份:2023
- 资助金额:
$ 3.78万 - 项目类别:
Coronary artery calcium synthetic cohort and lifetime percentile project (CACSC-LPP)
冠状动脉钙合成队列和终生百分位项目 (CACSC-LPP)
- 批准号:
10731429 - 财政年份:2023
- 资助金额:
$ 3.78万 - 项目类别:
Coronary artery dysfunction in OSA: Role of mineralocorticoid receptors
OSA 中的冠状动脉功能障碍:盐皮质激素受体的作用
- 批准号:
10734658 - 财政年份:2023
- 资助金额:
$ 3.78万 - 项目类别: